Latest Investment News

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

BWP Group has announced an estimated ordinary dividend of AUD 0.0958 per stapled security for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Kjerulf David Hastings Ainsworth has initiated an unconditional all-cash proportional takeover offer for 2.9% of Ainsworth Game Technology Ltd shares at $1.30 each, representing a significant premium over recent trading prices and a competing bid by Novomatic.

Identitii Limited launches a $2.9 million rights issue, underwritten up to $2.3 million by its largest shareholder, to accelerate the commercial rollout of its BNDRY platform.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

6K Additive has landed a landmark US$27.4 million loan from the US Export-Import Bank, partnering with the Department of War to fund a major expansion in Pennsylvania that will quintuple powder production capacity and create over 50 new jobs.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

L1 Global Long Short Fund Limited has successfully completed its shortfall offer bookbuild, prompting a $62 million institutional placement at $1.63 per share, adding to a total raise of up to $415 million. Trading is set to resume immediately following the announcement.

Global Lithium Resources has released a Definitive Feasibility Study for its Manna Lithium Project, confirming robust financials and a long mine life in Western Australia. The study sets the stage for a Final Investment Decision in 2026 amid improving lithium market conditions.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

FireFly Metals has raised approximately A$139 million to accelerate exploration and development at its Green Bay Copper-Gold Project in Canada, setting the stage for a major resource expansion and a Final Investment Decision in 2026.